LifeStance Health Group, Inc. Business Combination, Consideration Transferred, Equity Interests Issued and Issuable
LifeStance Health Group, Inc. (LFST) reported Business Combination, Consideration Transferred, Equity Interests Issued and Issuable of $381.82 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-09.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Consideration Transferred
us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable · last filed 2023-03-09
- LifeStance Health Group, Inc. business combination, consideration transferred, equity interests issued and issuable for the quarter ending 2021-12-31 was $0.00.
- LifeStance Health Group, Inc. business combination, consideration transferred, equity interests issued and issuable for the quarter ending 2021-09-30 was $0.00.
- LifeStance Health Group, Inc. business combination, consideration transferred, equity interests issued and issuable for fiscal 2022 was $381.82M, a 0.00% change from fiscal 2021.
- LifeStance Health Group, Inc. business combination, consideration transferred, equity interests issued and issuable for fiscal 2021 was $381.82M.
| Period end | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 3 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 6 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 9 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 12 month |
|---|---|---|---|---|
| 2022-12-31 | $381.82M 10-K · filed 2023-03-09 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $0.00 derived: sum of 2 quarters · filed 2022-03-17 | $381.82M 10-K · filed 2022-03-17 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $381.82M 10-Q · filed 2021-11-10 | ||
| 2021-06-30 | $381.82M 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |